BAMLANIVIMAB\ETESEVIMAB: 830 Adverse Event Reports & Safety Profile
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
830
Total FAERS Reports
17 (2.0%)
Deaths Reported
189
Hospitalizations
830
As Primary/Secondary Suspect
45
Life-Threatening
3
Disabilities
First Report: 19760330 · Latest Report: 20230524
What Are the Most Common BAMLANIVIMAB\ETESEVIMAB Side Effects?
#1 Most Reported
Infusion related reaction
309 reports (37.2%)
#2 Most Reported
Dyspnoea
172 reports (20.7%)
#3 Most Reported
Flushing
130 reports (15.7%)
All BAMLANIVIMAB\ETESEVIMAB Side Effects by Frequency
| Side Effect | Reports | % of Total | Deaths | Hosp. |
|---|---|---|---|---|
| Infusion related reaction | 309 | 37.2% | 2 | 38 |
| Dyspnoea | 172 | 20.7% | 2 | 46 |
| Flushing | 130 | 15.7% | 0 | 6 |
| Chest discomfort | 103 | 12.4% | 0 | 10 |
| Back pain | 83 | 10.0% | 0 | 13 |
| Nausea | 79 | 9.5% | 0 | 10 |
| Incorrect dose administered | 75 | 9.0% | 0 | 0 |
| Transcription medication error | 67 | 8.1% | 0 | 0 |
| Chest pain | 66 | 8.0% | 0 | 10 |
| Dizziness | 59 | 7.1% | 0 | 9 |
| Product dispensing error | 49 | 5.9% | 0 | 0 |
| Cough | 46 | 5.5% | 0 | 12 |
| Oxygen saturation decreased | 46 | 5.5% | 2 | 25 |
| Drug monitoring procedure not performed | 45 | 5.4% | 0 | 0 |
| Erythema | 44 | 5.3% | 0 | 2 |
| Feeling hot | 43 | 5.2% | 0 | 4 |
| Hyperhidrosis | 42 | 5.1% | 0 | 4 |
| Urticaria | 36 | 4.3% | 0 | 3 |
| Hypoxia | 33 | 4.0% | 0 | 27 |
| Headache | 32 | 3.9% | 0 | 3 |
Who Reports BAMLANIVIMAB\ETESEVIMAB Side Effects? Age & Gender Data
Gender: 58.5% female, 41.5% male. Average age: 51.3 years. Most reports from: US. View detailed demographics →
Is BAMLANIVIMAB\ETESEVIMAB Getting Safer? Reports by Year
| Year | Reports | Deaths | Hosp. |
|---|---|---|---|
| 2020 | 4 | 0 | 1 |
| 2021 | 736 | 14 | 175 |
| 2022 | 72 | 2 | 10 |
| 2023 | 1 | 0 | 0 |
What Is BAMLANIVIMAB\ETESEVIMAB Used For?
| Indication | Reports |
|---|---|
| Covid-19 | 556 |
| Covid-19 treatment | 85 |
| Sars-cov-2 test positive | 35 |
| Covid-19 prophylaxis | 8 |
| Coronavirus test positive | 5 |
| Covid-19 pneumonia | 5 |
BAMLANIVIMAB\ETESEVIMAB vs Alternatives: Which Is Safer?
BAMLANIVIMAB\ETESEVIMAB vs BARACLUDE
BAMLANIVIMAB\ETESEVIMAB vs BARICITINIB
BAMLANIVIMAB\ETESEVIMAB vs BARIUM
BAMLANIVIMAB\ETESEVIMAB vs BARNIDIPINE
BAMLANIVIMAB\ETESEVIMAB vs BASILIXIMAB
BAMLANIVIMAB\ETESEVIMAB vs BAYER GENUINE ASPIRIN ORIGINAL STRENGTH
BAMLANIVIMAB\ETESEVIMAB vs BAZEDOXIFENE\ESTROGENS, CONJUGATED
BAMLANIVIMAB\ETESEVIMAB vs BCG VACCINE
BAMLANIVIMAB\ETESEVIMAB vs BEBTELOVIMAB
BAMLANIVIMAB\ETESEVIMAB vs BECLOMETHASONE
Official FDA Label for BAMLANIVIMAB\ETESEVIMAB
Official prescribing information from the FDA-approved drug label.